Compare ERII & EMBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ERII | EMBC |
|---|---|---|
| Founded | 1992 | 1924 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 740.3M | 719.7M |
| IPO Year | 2008 | N/A |
| Metric | ERII | EMBC |
|---|---|---|
| Price | $14.22 | $12.74 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 2 |
| Target Price | $16.50 | ★ $18.50 |
| AVG Volume (30 Days) | 406.0K | ★ 596.9K |
| Earning Date | 02-25-2026 | 02-05-2026 |
| Dividend Yield | N/A | ★ 4.74% |
| EPS Growth | 7.56 | ★ 20.90 |
| EPS | 0.36 | ★ 1.62 |
| Revenue | $135,191,000.00 | ★ $1,080,400,000.00 |
| Revenue This Year | $5.93 | $2.18 |
| Revenue Next Year | $8.97 | $0.09 |
| P/E Ratio | $40.32 | ★ $7.81 |
| Revenue Growth | ★ 0.10 | N/A |
| 52 Week Low | $10.86 | $9.20 |
| 52 Week High | $18.32 | $20.63 |
| Indicator | ERII | EMBC |
|---|---|---|
| Relative Strength Index (RSI) | 49.56 | 57.84 |
| Support Level | $14.10 | $12.51 |
| Resistance Level | $14.55 | $13.03 |
| Average True Range (ATR) | 0.35 | 0.42 |
| MACD | 0.07 | 0.15 |
| Stochastic Oscillator | 71.26 | 84.85 |
Energy Recovery Inc is an engineering-driven technology company. It is engaged in engineering, designing, manufacturing and supplying solutions that make industrial processes more efficient and sustainable. The company operates in three segments, Water, Emerging Technologies and Corporate. It offers energy recovery devices (ERDs) and pumps as well as related products and services to the reverse osmosis desalination market. The company derives a majority of the revenue from the Water segment. Geographically, the company operates in the U.S. and other international countries.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.